Turmeric extract shows promise for schizophrenia symptoms in small trial

NCT ID NCT07523256

First seen Apr 15, 2026 · Last updated May 14, 2026 · Updated 5 times

Summary

This study tested whether adding curcumin (the active compound in turmeric) to the standard medication risperidone could improve quality of life and reduce inflammation in people with schizophrenia. Forty-four men took either risperidone alone or risperidone plus curcumin for 8 weeks. Researchers measured changes in quality of life and levels of an inflammatory marker called IL-1β.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Rumah Sakit Khusus Daerah (RSKD) Dadi Provinsi Sulawesi Selatan

    Makassar, South Sulawesi, 90113, Indonesia

Conditions

Explore the condition pages connected to this study.